Oxidative stress response, cell proliferation, and apoptosis in patients with synthetic cannabinoid use disorder

Martínez, 2021, Acute pharmacological effects and oral fluid concentrations of the synthetic cannabinoids JWH-122 and JWH-210 in humans after self-administration: an observational study, Front Pharmacol, 12, 705643, 10.3389/fphar.2021.705643 Almada, 2020, Synthetic cannabinoids JWH-018, JWH-122, UR-144 and the phytocannabinoid THC activate apoptosis in placental cells, Toxicol Lett, 319, 129, 10.1016/j.toxlet.2019.11.004 United Nations Office on Drugs and Crime (UNODC), 2020 Solimini, 2017, Hepatotoxicity associated to synthetic cannabinoids use, Eur Rev Med Pharmacol Sci, 21, 1 Pacher, 2018, Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly, Nat Rev Cardiol, 15, 151, 10.1038/nrcardio.2017.130 Castellanos, 2016, Synthetic cannabinoids 2015: an update for pediatricians in clinical practice, World J Clin Pediatr, 5, 16, 10.5409/wjcp.v5.i1.16 Ferk, 2016, Genotoxic properties of XLR-11, a widely consumed synthetic cannabinoid, and of the benzoyl indole RCS-4, Arch Toxicol, 90, 3111, 10.1007/s00204-016-1664-4 Koller, 2014, Investigation of the in vitro toxicological properties of the synthetic cannabimimetic drug CP-47,497-C8, Toxicol Appl Pharmacol, 277, 164, 10.1016/j.taap.2014.03.014 Guler, 2020, Investigation of DNA damage, oxidative stress, and inflammation in synthetic cannabinoid users, Hum Exp Toxicol, 39, 1454, 10.1177/0960327120930057 Pizzino, 2017, Oxidative stress: harms and benefits for human health, Oxid Med Cell Longev, 2017, 8416763, 10.1155/2017/8416763 Dalleau, 2013, Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance, Cell Death Differ, 20, 1615, 10.1038/cdd.2013.138 Reuter, 2010, Oxidative stress, inflammation, and cancer: how are they linked?, Free Radic Biol Med, 49, 1603, 10.1016/j.freeradbiomed.2010.09.006 Kaplowitz, 2000, Mechanisms of liver cell injury, J Hepatol, 32, 3947, 10.1016/S0168-8278(00)80414-6 Birben, 2012, Oxidative stress and antioxidant defense, World Allergy Organ J, 5, 9, 10.1097/WOX.0b013e3182439613 Su, 2019, Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis, Oxid Med Cell Longev, 2019, 5080843, 10.1155/2019/5080843 Breitzig, 2016, 4-Hydroxy-2-nonenal: a critical target in oxidative stress?, Am J Physiol Cell Physiol, 311, C537, 10.1152/ajpcell.00101.2016 Ayala, 2014, Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal, Oxid Med Cell Longev, 2014, 360438, 10.1155/2014/360438 Tian, 2021, Oxidative stress drives divergent evolution of the glutathione peroxidase (GPX) gene family in mammals, Integr Zool, 16, 696, 10.1111/1749-4877.12521 Miyamoto, 2003, Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses, Biol Chem, 384, 567, 10.1515/BC.2003.064 Kang, 2010, Myricetin protects cells against oxidative stress-induced apoptosis via regulation of PI3K/AKT and MAPK signaling pathways, Int J Mol Sci, 11, 4348, 10.3390/ijms11114348 Redza-Dutordoir, 2016, Activation of apoptosis signalling pathways by reactive oxygen species, Biochim Biophys Acta, 1863, 2977, 10.1016/j.bbamcr.2016.09.012 Kuida, 2000, Caspase-9, Int J Biochem Cell Biol, 32, 121, 10.1016/S1357-2725(99)00024-2 First, 1997 El Missiry, 2004 Chan, 2003, Biostatistics102: quantitative data – parametric & non-parametric tests, Singapore Med J, 44, 391 Chan, 2003, Biostatistics 104: correlational analysis, Singapore Med J, 44, 614 Castellanos, 2012, Synthetic cannabinoid use: recognition and management, J Psychiatr Pract, 18, 86, 10.1097/01.pra.0000413274.09305.9c Abdelmoneim, 2022, Clinical pattern of synthetic cannabinoids users in Upper Egypt: cross-sectional study, Middle East Curr Psychiatry, 29, 24, 10.1186/s43045-022-00188-y Johnston, 2014 Loefer, 2016, International trends in spice use: prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids, Brain Res Bull, 126, 8, 10.1016/j.brainresbull.2016.04.013 Barratt, 2013, Patterns of synthetic cannabinoid use in Australia, Drug Alcohol Rev, 32, 141, 10.1111/j.1465-3362.2012.00519.x Vandrey, 2012, A survey study to characterize use of Spice products (synthetic cannabinoids), Drug Alcohol Depend, 120, 238, 10.1016/j.drugalcdep.2011.07.011 Cohen, 2017, The efects of synthetic cannabinoids on executive function, Psychopharmacology, 234, 1121, 10.1007/s00213-017-4546-4 Stogner, 2014, A spicy kind of high: a profle of synthetic cannabinoid users, J Subst Abuse Treat, 19, 199 Coviello, 2004, The role of family history in addiction severity and treatment response, J Subst Abuse Treat, 26, 303, 10.1016/S0740-5472(03)00143-0 Sezer, 2020, In vitro assessment of the cytotoxic, genotoxic and oxidative stress effects of the synthetic cannabinoid JWH-018 in human SH-SY5Y neuronal cells, Toxicol Res, 9, 734, 10.1093/toxres/tfaa078 Bayazit, 2017, Evaluation of oxidant/antioxidant status and cytokine levels in patients with cannabis use disorder, Clin Psychopharmacol Neurosci, 15, 237, 10.9758/cpn.2017.15.3.237 Gallelli, 2018, Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid analogues, Antioxidants, 7, 93, 10.3390/antiox7070093 Łuczaj, 2017, Antioxidants and HNE in redox homeostasis, Free Radic Biol Med, 111, 87, 10.1016/j.freeradbiomed.2016.11.033 Viarengo, 2007, The use of biomarkers in biomonitoring: a 2-tier approach assessing the level of pollutant-induced stress syndrome in sentinel organisms, Comp Biochem Physiol C Toxicol Pharmacol, 146, 281, 10.1016/j.cbpc.2007.04.011 Ligresti, 2016, From phytocannabinoids to cannabinoid receptors and endocannabinoids: Pleiotropic physiological and pathological roles through complex pharmacology, Physiol Rev, 96, 1593, 10.1152/physrev.00002.2016 Di Marzo, 2018, New approaches and challenges to targeting the endocannabinoid system, Nat Rev Drug Discov, 17, 623, 10.1038/nrd.2018.115 Jastrząb, 2019, Cannabidiol regulates the expression of keratinocyte proteins involved in the inflammation process through transcriptional regulation, Cells, 8, 827, 10.3390/cells8080827 Archie, 2019, Harmful effects of smoking cannabis: a cerebrovascular and neurological perspective, Front Pharmacol, 10, 1481, 10.3389/fphar.2019.01481 Giacoppo, 2015, A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis, Daru, 23, 48, 10.1186/s40199-015-0131-8 McKallip, 2006, Cannabidiol-induced apoptosis in human leukemia cells: a novel role of cannabidiol in the regulation of p22phox and Nox4 expression, Mol Pharmacol, 70, 897, 10.1124/mol.106.023937 Gómez del Pulgar, 2000, The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/AKT, Biochem J, 347, 369, 10.1042/bj3470369 Ellert-Miklaszewska, 2005, Cannabinoids down-regulate PI3K/AKT and Erk signalling pathways and activate proapoptotic function of bad protein, Cell Signal, 17, 25, 10.1016/j.cellsig.2004.05.011 Molina-Holgado, 2002, Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/AKT signaling, J Neurosci, 22, 9742, 10.1523/JNEUROSCI.22-22-09742.2002 George, 2008, Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells, J Cell Physiol, 214, 714, 10.1002/jcp.21263 Sultan, 2018, Novel mechanism of cannabidiol-induced apoptosis in breast cancer cell lines, Breast, 41, 34, 10.1016/j.breast.2018.06.009